Address

Pfizer Inc
235 East 42nd Street
150/39/18
New York, NY 10017
United States

Open map


Recent investment activity

KANDO id: 4229

Corporate information

Official name
Pfizer Incorporated
Registration country

Funding rounds

Top investment portfolio themes


Investment activity status
Active investor

Selected investments

Displaying 1 - 20 of 24
Profile Country Date Funding
Ablexis LLC Biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery. N/A
BioRexis Pharmaceutical Corp Acquisition
Celladon Corp N/A
Coley Pharmaceutical Group Inc N/A
DVS Sciences Inc An analytical instrument and reagents company founded in Toronto Series A
Esperion Therapeutics Inc N/A
Excaliard Pharmaceuticals Inc N/A
Five Prime Therapeutics Inc N/A
Five Prime Therapeutics Inc N/A
FoldRx Pharmaceuticals Inc Acquisition
Icagen Inc Biopharmaceutical company developing small molecule therapeutics that target ion channels for treatment of a variety of diseases. Acquisition USD 56,000,000 (USD 56,000,000)
IDUN Pharmaceuticals Inc Acquisition
Neuronetics Inc Series E
NeuroTherapeutics Pharma Inc N/A
Serenex Inc Oncology-focused drug development company Acquisition
TetraLogic Pharmaceuticals A leader in the discovery and development of small molecule drugs called Smac mimetics for the treatment of cancers. Series C (USD 5,000,000)
Vicuron Pharmaceuticals Inc Acquisition USD 1,900,000,000 (USD 1,900,000,000)
Anacor Pharmaceuticals Inc Acquisition Initial investment led the round USD 5,200,000,000 (USD 5,200,000,000)
Avid Radiopharmaceuticals Inc Series A
Avid Radiopharmaceuticals Inc Series C

Current team

Employee Position
[node:title] photo Barbara J Dalton

Financials